Objective: The objective of the study is to report the incidence and pregnancy outcome of autosomal aneuploidies other than common trisomies 21, 18, and 13 detected by noninvasive prenatal testing (NIPT) at a single center.
Conclusions: Autosomal aneuploidies other than trisomies 21, 18, and 13 are not uncommon in routine clinical NIPT practice. Extra copies of chromosomes in rare cases can be associated with uniparental disomy. Most rare aneuploidies at NIPT have good pregnancy outcomes. Thus, invasive testing should be used with caution for these aneuploidies in routine clinical practice.
| INTRODUCTION
The discovery of cell-free fetal DNA in maternal plasma and the invention of massively parallel sequencing (MPS) have made noninvasive prenatal testing (NIPT) for fetal common aneuploidies (trisomies 13, 18 , and 21) a clinical reality. 1 Noninvasive prenatal testing has been recommended as a first-tier or second-tier screening test for fetal common trisomies, with lower false-positive rates and higher positive predictive values than serum biochemical screening. 2 Noninvasive prenatal testing can also enable the detection of other aneuploidies, including sex chromosome aneuploidies (SCA) and structural chromosomal abnormalities. [3] [4] [5] [6] [7] However, most of the published data have mainly focused on 3 common aneuploidies, SCA, and subchromosomal deletions/duplications. Reports on the incidence and pregnancy outcome of autosomal aneuploidies other than common trisomies detected at NIPT are still limited. For this reason, report of such unexpected autosomal aneuploidies often makes genetic counseling difficult and results in anxiety; women opting for invasive diagnostic procedures must balance the known risks of such procedures with the unknown effects of the rare aneuploidies on pregnancy outcome. 8 The objective of this study was to review the screen-positive rate and pregnancy outcome of autosomal aneuploidies other than common trisomies detected at NIPT over the past 3 years at a single center, and to propose a clinic workflow and counseling for these aneuploidies.
| METHODS

| Patients and sample collection
This was a retrospective analysis of a cohort of NIPT cases performed at a single prenatal diagnosis center, Guangzhou Women and Children's Medical Centre in China, from the beginning of the service in February 2015 to January 2018. The test protocol required that the pregnancy had to be above 12 gestational weeks.
All patients underwent pretest counseling, during which they were informed of the option to screen for autosomal aneuploidies other than trisomies 21, 13, and 18. A pretest ultrasound scan to ascertain the number of fetuses and gestational age and to exclude major structural abnormalities was recommended to all cases. Pregnancies conceived via in vitro fertilization (IVF) and multiples were accepted for NIPT.
Five milliliters of maternal peripheral blood was collected into EDTA anticoagulation tubes. The blood sample was stored immediately at 4°C before further processing. Plasma was prepared within 8 hours of collection using a 2-step centrifugation protocol. The maternal blood sample was first centrifuged at 1600g for 10 minutes at 4°C, then centrifuged at 16 000g for 10 minutes at 4°C with 2.0 mL with transfer of supernatant into Eppendorf tubes. The final supernatant was transferred to new EP tubes, which were temporarily stored at −20°C if DNA extraction was not performed immediately.
Each plasma sample was frozen and thawed only once.
| NIPT
Noninvasive prenatal testing procedures, including cell-free DNA isolation, library construction, and next-generation sequencing, were performed in our NIPT laboratory with Ion Proton semiconductor sequencer (Life Technologies). Full details about the NIPT test and data analysis were reported in our previous article. 5 In brief, singleend sequencing by whole genome sequencing of plasma DNA was carried out on each sample resulting in beyond 3 Mb unique effective reads. GC bias was eliminated by using bioinformatic methods described previously, and a binary hypothesis t test method was used to determine aneuploidy for all 23 pairs of chromosomes. Fetal aneuploidies were identified using the criteria of z score >3 or <−3.
Aneuploidies included extra copy chromosomes (most likely trisomies) and decreased copy chromosomes (most likely monosomies);
however, an increased NIPT score cannot establish the number of extra chromosomes. Cases with an increased or decreased z score because of maternal copy number variants (CNV) were not consid- 
| Confirmatory invasive testing
Karyotyping and microarray analysis were provided to subjects who chose invasive prenatal testing. Chromosomal karyotyping was per- based on the GRCh37/hg19 assembly.
| Genetic counseling and follow-up contacts
Patients with suspected rare autosomal aneuploidies underwent genetic counseling, during the course of which the possible explanations for the NIPT results were discussed, including fetus not affected, fetal mosacism, fetal growth restriction (FGR), or uniparental disomy (UPD). Subsequent management depended on the patients' choices.
Affected pregnancies were followed up with serial prenatal ultrasound examinations. Patients were contacted to establish pregnancy outcome.
| Statistical analysis
The data were analyzed using SPSS software v22. 
| DISCUSSION
Our study shows that autosomal aneuploidies beyond trisomies 21, 18, and 13 and SCA are common in clinical NIPT practice. Overall, the screen-positive rate of these autosomal aneuploidies in this cohort was 0.38% which is higher than that of 3 common trisomies in the normal population. 10 The incidence of these aneuploidies was similar to the recent report by Brison et al. 11 In this real clinical data, the rate of high-risk serum screening results as indication for NIPT (86.5%) was higher than previously reported in the literature 12 possibly because of What's already known about this topic?
• Noninvasive prenatal testing has the potential to detect aneuploidies other than common trisomies, such as sex chromosome aneuploidies and subchromosomal abnormalities.
• Counseling related to autosomal aneuploidies beyond common trisomies is made difficult by limited case reports.
What does this study add?
• We report the positive screening rate and pregnancy outcome of autosomal aneuploidies other than trisomies 21, 18, and 13 detected by NIPT at a single center.
• Some rare aneuploidies can lead to uniparental dysomy, in particular when affecting chromosomes involved in known imprinting disorders.
• We propose a clinic workflow for genetic counseling regarding these aneuploidies. the different selected study population. As already known for Down syndrome, the screen-positive rate of rare aneuploidies is higher in patients over 35 years, likely because of a higher chance of chromosome mis-segregation and unequal distribution with advanced maternal age.
Following the abnormal NIPT results, more than half of patients (61% vs 39%) underwent invasive testing in our study. Most of the rare autosomal aneuploidies detected by NIPT were false positives, and they did not affect the fetus. Confined placental mosaicism (CPM) was suspected in most cases 11 because no structural abnormalities were identified by prenatal ultrasound examination or clinical follow-up in these patients. Similar to a previous report on incidence of trisomic CPM in diagnostic chorionic villus sampling procedures, 13 extra copies of chromosome 7 was the most common one found in our study. Confined placental mosaicism may result in a spectrum of fetal outcomes, from no clinical phenotype to fetal growth restriction. Russell-Silver, 21, 22 Beckwith-Wiedemann syndrome, 23 Temple syndrome, 24 UPD (14) 
